Dr. Marc Penn is the CEO of Black Beret Life Sciences (Houston, TX) where he oversees the life science investments of the Bosarge Family Office. Dr. Penn directs the strategy at Tissue Genesis, LLC, (Honolulu, HI), Advanced Regen Medical Technologies, LLC, (Newark NJ), the novel sugar replacement Sola (Houston, TX), and the stem cell treatment center, Okyanos (Freeport Bahamas). A cardiologist and Director of Research at the Summa Cardiovascular Institute in Akron, OH, Dr. Penn is also Professor of Medicine at Northeast Ohio Medical University where he leads the Skirball Laboratory for Cardiovascular Cellular Therapeutics (Rootstown, OH).
With nearly two decades of work in stem cell biology, regenerative and translational medicine, Dr. Greco serves as Chief Science Officer for Okyanos Innovation Labs and BBLS. Dr. Greco also oversees Rejenevie, an immune restoration therapy based on the science of parabiosis. An author on more than 55 research publications, Dr. Greco directs translational scientific research at Okyanos Innovation labs and first in man therapies such as Rejenevie. Dr. Greco and his team have treated 5 patients with Rejenevie. Patient 1 on December 15, 2017, Patient 5 on February 28, 2019. Rejenevie is awaiting regulatory permission in the Bahamas to begin treating the next group of patients.
Eric Schaeffer is General Counsel to and serves on the Board of Managers of Black Beret Life Sciences, LLC. He also currently serves as President and General Counsel of Capital Technologies, Inc., and the Bosarge Family Office. Prior to joining the Bosarge Family Office in 2010, Mr. Schaeffer’s extensive business law practice included the areas of corporate and partnership law, mergers and acquisitions, real estate transactions, financing transactions, licensing transactions, and a myriad of other business transactions. In addition to representing established corporate clients, Mr. Schaeffer is particularly attuned to the needs of the entrepreneur.
Mark Benerofe is a highly sought after executive and consultant working in high tech, media and biotech companies. He has served in senior executive roles at Priceline, Sony, Microsoft, Prodigy and CNN, and has been a founder and advisor to numerous startups including Boxbe, Sony Online Entertainment and Match.com.
Lori Butterfield is a highly creative communications and marketing executive who brings a wealth of digital production expertise to her role at BBLS. She combines high level strategy with a hands-on approach to enhance the vision, mission and reputation of the BBLS portfolio of companies.
Rajesh (R.K.) Khosla is Chief Business Officer of Black Beret Life Sciences, LLC. R.K. was most recently CEO at Laguna Pharmaceuticals (formerly ChanRx Corp.), a company developing a multi-channel drug for the treatment of atrial fibrillation/atrial flutter, taking it through a very successful Phase 2b and raising $30M for a Phase 3 study. Simultaneously, he was CEO-in-Residence at BioEnterprise Corp. helping companies to accelerate their growth to benefit the Northeastern Ohio economy. Previously, R.K. was CEO of PeriTec Biosciences Ltd., a medical device spin-off of the Cleveland Clinic Foundation.
A Certified Public Accountant with controller and accounting experience across a diverse set of industries doing business around the globe, Cathy joined BBLS in October 2016. Her multi-disciplinary financial skills are a unique and valuable addition to the BBLS team providing financial strategy and oversight as Controller. Cathy’s resume covers a range of industries as Controller: medical diagnostic testing, aerospace, petrochemicals, energy, logistics, technology infrastructure and security and venture capital.
A passionate believer in the power of regenerative medicine to treat disease and to promote a longer, healthier life, W. E. "Ed" Bosarge has launched and supported a wide variety of research and development efforts. Dr. Bosarge founded Black Beret Life Sciences LLC to invest in game-changing biotechnology innovations. Since 2014, Black Beret Life Sciences has funded research for treatments based on regenerative medicine for cancer, diabetes, neurodegeneration, osteoarthritis, and other conditions related to aging.